ºÃÎĵµ - רҵÎÄÊéд×÷·¶ÎÄ·þÎñ×ÊÁÏ·ÖÏíÍøÕ¾

Baseline Naive CD4+ T-cell Level Predicting Immune Reconstitution in Treated HIV-infected

ÓÉ ÌìÏ ·ÖÏí ʱ¼ä£º ¼ÓÈëÊÕ²Ø ÎÒҪͶ¸å µãÔÞ

Baseline Naive CD4+ T-cell Level Predicting Immune Reconstitution in Treated HIV-infected

Late Presenters

Fu-Ping Guo;Yi-Jia Li;Zhi-Feng Qiu;Wei Lv;Yang Han;Jing Xie;Yan-Ling Li

¡¾ÆÚ¿¯Ãû³Æ¡¿¡¶ÖлªÒ½Ñ§ÔÓÖ¾£¨Ó¢Îİ棩¡· ¡¾Äê(¾í),ÆÚ¡¿2016(129)022

¡¾ÕªÒª¡¿Background:Among HlV-infected patients initiating antiretroviral therapy (ART),early changes in CD4+ T-cell subsets are well described.However,HIV-infected late presenters initiating treatment present with a suboptimal CD4+ T-cell reconstitution and remain at a higher risk for AIDS and non-AIDS events.Therefore,factors associated with CD4+ T-cell reconstitution need to be determined in this population,which will allow designing effective immunotherapeutic strategies.Methods:Thirty-one adult patients with baseline CD4+ T-cell count £¼350 cells/mm3 exhibiting viral suppression after ART initiation were followed in the HIV/AIDS research center of Peking Union Medical College Hospital in Beijing,China,from October 2002 to September 2013.Changes in T-cell subsets and associated determinants were measured.Results:Median baseline CD4+ T-cell count was 70 cells/mm3.We found a biphasic reconstitution ofT-cell subsets and immune activation:a rapid change during the first 6 months followed by a more gradual change over the subsequent 8 years.Baseline CD4+ T-

Baseline Naive CD4+ T-cell Level Predicting Immune Reconstitution in Treated HIV-infected

BaselineNaiveCD4+T-cellLevelPredictingImmuneReconstitutioninTreatedHIV-infectedLatePresentersFu-PingGuo;Yi-JiaLi;Zhi-FengQiu;WeiLv;YangHan;JingXie;Yan-LingL
ÍƼö¶È£º
µã»÷ÏÂÔØÎĵµÎĵµÎªdoc¸ñʽ
3izxi016fs862m61dk4v721et5ixox005od
ÁìÈ¡¸£Àû

΢ÐÅɨÂëÁìÈ¡¸£Àû

΢ÐÅɨÂë·ÖÏí